Jennifer Nicholson

Jennifer Nicholson's Title

Jennifer Nicholson serves as the Senior Vice President of Regulatory Affairs and Quality Assurance at RAPT. In this capacity, she oversees regulatory strategy and compliance, ensuring that RAPT's products meet all regulatory standards. Her role is crucial in navigating the complex landscape of biotechnology and pharmaceutical regulations, which is pivotal for the company's success and growth.

Jennifer Nicholson's Company

Jennifer Nicholson joined RAPT in September 2022, bringing with her a wealth of experience from the biotechnology and pharmaceutical sectors. RAPT is a company focused on developing therapies for oncology and inflammatory diseases. With Nicholson's expertise, the company is well-positioned to advance its pipeline of innovative treatments through the regulatory pathways efficiently and effectively.

Jennifer Nicholson's Experience

With over 20 years of experience in the biotechnology and pharmaceutical industries, Jennifer Nicholson has a proven track record across all stages of drug development, particularly in oncology. Her extensive background includes significant roles in hematologic malignancies and solid tumors. Prior to joining RAPT, she was the Vice President of Regulatory Affairs at Kronos Bio and the Head of Global Regulatory Science at Acerta Pharma, where she played a pivotal role in the regulatory approval of Calquence (acalabrutinib). Her career also includes key positions at Bavarian Nordic, Jazz Pharmaceuticals, Onyx Pharmaceuticals, and Genentech.

Jennifer Nicholson's Achievements

One of Jennifer Nicholson's notable achievements includes leading the regulatory efforts for the Calquence (acalabrutinib) US NDA, which received accelerated approval in 2017. This accomplishment highlights her expertise in navigating complex regulatory environments and her ability to bring critical therapies to market efficiently. Her work has had a significant impact on the treatment landscape for oncology, particularly in hematologic malignancies and solid tumors.

Jennifer Nicholson's Education and Expertise

Jennifer Nicholson holds a Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego, and a Master of Health Administration from the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Her educational background laid a strong foundation for her career in regulatory affairs and quality assurance, providing her with the scientific knowledge and administrative skills necessary to excel in the biotechnology and pharmaceutical industries.